The detection of autoantibodies against type 3 muscarinic acetylcholine receptor in Sj(o)gren's syndrome

Bei LAI,Qiao-lin CHEN,Cui-hua ZHANG,Zhen-gang WANG,Zhan-guo LI

DOI: https://doi.org/10.3760/j:issn:1007-7480.2005.07.007

2005-01-01

Abstract:Objective To detect anti-M3 autoantibodies in Sjgren′s syndrome (SS) patients and to explore its association with clinical manifestation. Methods Anti-M3 autoantibodies were tested in 80 patients with SS, 80 with other rheumatic diseases and 40 normal controls using Western blot. The correlation between anti-M3 autoantibodies and clinical data of SS was analyzed. Results {1}The positive rate of anti-M3 antibodies was 83.8% in SS, 2.5% in other rheumatic diseases and 2.5% in normal controls. {2}Its sensitivity was 83.8% and specificity was 97.5% in SS with a positive predictive rate of 95.7% and negative prediction rate of 90.0%. {3}The positive rate of anti-M3 antibodies was 80.0%, 82.5% and 81.2% in SS with SSA, SSB and ?琢-Fodrin antibodies negative group, and 87.5%, 88.2% and 85.4% respectively in above antibodies positive group 4. The incidence of organ involvement, IgG, IgA and ESR elevation was not significantly different in anti-M3 antibodies positive and negative group. There was no significant difference in dry eye and dry mouth between antibody positive and negative group. Conclusion Human recombinant M3 muscarinic receptor expressed in sf9 cells can be used to detect anti-M3 autoantibodies in the serum from SS patient. The antibody may be a new and specific serum maker for the diagnosis of SS.